Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SAB Biotherapeutics’ SAB-185 shows activity against Omicron variant in study

Pharmaceutical-TechnologyDecember 20, 2021

Tag: SAB Biotherapeutics , SAB-185 , Omicron variant

PharmaSources Customer Service